🇺🇸 FDA
Pipeline program

SUSTOL

HTX-100-403

Approved small_molecule active

Quick answer

SUSTOL for Chemotherapy-Induced Nausea and Vomiting (CINV) is a Approved program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Heron Therapeutics
Indication
Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials